The assessment of maduramicin ammonium alpha shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised as specified in the Annex to this Regulation.
Recital 5, Commission Implementing Regulation (EU) No 388/2011 of 19 April 2011 concerning the auth…
In forcesince 19 Apr 2011